Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (101-110 of 450) with videos related to

Pageof 45
Sort By:
Glia|August 19, 2014
Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathwayMartina Ott, Ulrike M Litzenburger, Katharina J Rauschenbach, et al.
Acta Neuropathologica Communications|February 12, 2026
MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastomaObada T Alhalabi, Lukas Klein, Kirill Mironov, et al.
Genes & Development|August 25, 2022
Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in miceFrank Szulzewsky, Sonali Arora, Aleena K S Arakaki, et al.
Neuro-Oncology|November 13, 2024
Meningiomas: Sex-specific differences and prognostic implications of a chromosome X lossNatalie Berghaus, Thomas Hielscher, Dilan Savran, et al.
Cancer Discovery|January 13, 2025
Cancer Neuroscience of Brain Tumors: From Multicellular Networks to Neuroscience-Instructed Cancer TherapiesVarun Venkataramani, Yvonne Yang, Sebastian Ille, et al.
Translational Oncology|September 11, 2020
Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02Caroline von Achenbach, Emilie Le Rhun, Felix Sahm, et al.
Acta Neuropathologica|March 24, 2018
Molecular characterization of medulloblastomas with extensive nodularity (MBEN)Andrey Korshunov, Felix Sahm, Damian Stichel, et al.
Acta Neuropathologica|June 21, 2022
Atypical NMDA receptor expression in a diffuse astrocytoma, MYB- or MYBL1-altered as a trigger for autoimmune encephalitisMarc Nikolaus, Arend Koch, Werner Stenzel, et al.
Plos One|July 29, 2016
Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei CountingOliver Eidel, Jan-Oliver Neumann, Sina Burth, et al.
Plos One|April 5, 2013
Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastomaAndreas Deistung, Ferdinand Schweser, Benedikt Wiestler, et al.
Pageof 45

Showing results (101-110 of 450) with videos related to

Sort By:
Pageof 45
Glia|August 19, 2014
Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathwayMartina Ott, Ulrike M Litzenburger, Katharina J Rauschenbach, et al.
Acta Neuropathologica Communications|February 12, 2026
MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastomaObada T Alhalabi, Lukas Klein, Kirill Mironov, et al.
Genes & Development|August 25, 2022
Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in miceFrank Szulzewsky, Sonali Arora, Aleena K S Arakaki, et al.
Neuro-Oncology|November 13, 2024
Meningiomas: Sex-specific differences and prognostic implications of a chromosome X lossNatalie Berghaus, Thomas Hielscher, Dilan Savran, et al.
Cancer Discovery|January 13, 2025
Cancer Neuroscience of Brain Tumors: From Multicellular Networks to Neuroscience-Instructed Cancer TherapiesVarun Venkataramani, Yvonne Yang, Sebastian Ille, et al.
Translational Oncology|September 11, 2020
Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02Caroline von Achenbach, Emilie Le Rhun, Felix Sahm, et al.
Acta Neuropathologica|March 24, 2018
Molecular characterization of medulloblastomas with extensive nodularity (MBEN)Andrey Korshunov, Felix Sahm, Damian Stichel, et al.
Acta Neuropathologica|June 21, 2022
Atypical NMDA receptor expression in a diffuse astrocytoma, MYB- or MYBL1-altered as a trigger for autoimmune encephalitisMarc Nikolaus, Arend Koch, Werner Stenzel, et al.
Plos One|July 29, 2016
Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei CountingOliver Eidel, Jan-Oliver Neumann, Sina Burth, et al.
Plos One|April 5, 2013
Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastomaAndreas Deistung, Ferdinand Schweser, Benedikt Wiestler, et al.
Pageof 45